We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patent Rulings Could Land Canada on USTR’s Priority Watch List
Patent Rulings Could Land Canada on USTR’s Priority Watch List
U.S. lawmakers are asking the Office of the United States Trade Representative to put Canada back on its priority watch list after the country withdrew a number of patents for drugs sold by American manufacturers.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor